Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
about
Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumorsMst1 and Mst2 kinases: regulations and diseasesA coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)Yap1 acts downstream of α-catenin to control epidermal proliferationRegulation of the Hippo-YAP pathway by G-protein-coupled receptor signalingPTPN14 is required for the density-dependent control of YAP1Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAPKibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and ExpandedMerlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleusA molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signallingOpposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnoverRegulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathwayAjuba LIM proteins are negative regulators of the Hippo signaling pathwayMammalian ste20-like kinase and SAV1 promote 3T3-L1 adipocyte differentiation by activation of PPARγWW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZLigand binding to WW tandem domains of YAP2 transcriptional regulator is under negative cooperativityβ-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesisNf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG developmentTAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathwayMammalian MST2 kinase and human Salvador activate and reduce estrogen receptor alpha in the absence of ligandInteraction proteome of human Hippo signaling: modular control of the co-activator YAP1PTPN14 interacts with and negatively regulates the oncogenic function of YAPNuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathwaysAngiomotin-like proteins associate with and negatively regulate YAP1Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120Angiomotin is a novel Hippo pathway component that inhibits YAP oncoproteinTEAD mediates YAP-dependent gene induction and growth controlHippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancerThe hippo signaling pathway in development and cancerα-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1Hippo pathway-independent restriction of TAZ and YAP by angiomotinStructural and functional analysis of the YAP-binding domain of human TEAD2Nuclear DBF-2-related kinases are essential regulators of cytokinesis in bloodstream stage Trypanosoma bruceiThe neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAPExpression of Yes-associated protein in common solid tumorsWilling to Be Involved in CancerMechanoregulation of Wound Healing and Skin HomeostasisThe Roles of NDR Protein Kinases in Hippo SignallingEnvironmental Ligands of the Aryl Hydrocarbon Receptor and Their Effects in Models of Adult Liver Progenitor CellsHedgehog Signaling in Pancreatic Fibrosis and Cancer
P2860
Q21260378-461CF086-4857-4B85-8849-5A80E346F593Q22001145-76CA1AA9-B74A-48AE-8C94-3B50222E8A0DQ24293710-85BE2D65-A180-48D8-8288-6CA85CC9DF67Q24294904-950FDD0C-A6AE-4F3B-81AE-DB3D606EB229Q24294906-B2074192-0FBA-4426-94D5-277AB87082ABQ24297998-A2019B1D-86E5-4C79-A4E8-F13C3E0A1109Q24298571-9DEFA7FA-9442-4760-9AB4-2BC8BA0C94D8Q24299457-48019610-92C3-4208-AF6D-B2ECAEFBCBF4Q24300770-0994F2E7-CCE2-4694-AF23-961A77F7ADA0Q24301588-83A4868F-AF47-43DD-AC66-3FA30DBD8F1FQ24303432-46A0E0FF-3BBC-4306-99BD-65C8778F7079Q24303511-416ED12E-3373-4D2A-B907-831ED9DA417AQ24304074-BA91917E-7C45-40D0-91C2-4CF3F813BBFCQ24304151-F71E11A0-B4B5-48EE-BD49-11C9652B2330Q24304338-9C394FE8-978C-46B3-9E4E-2C3EEE583BEBQ24305170-7CA8E018-386D-40FF-8ED0-89CE42FFE8E7Q24306274-54684167-6DFE-435A-86E2-3F8FC4353752Q24307540-6EBC1734-40C2-43CB-A5EF-6F9E485ED657Q24307937-926A3168-703C-47C4-8155-41F0FA819D01Q24308077-BC33D740-77CC-4440-9FD3-D27B9AE3E769Q24316087-71EF0B3A-0D66-4646-87C8-3081FAE6416CQ24316475-17F5EDB6-27D2-4816-BC5F-05C6BB8B3291Q24317164-9AE8800F-4767-4494-8D42-42E973864727Q24321532-80C36118-AC82-434A-B9E9-A8ED5AFDE9C2Q24321602-D7989FDA-6EBB-45DB-AD8A-B57DD7080EFFQ24323326-09951F22-EC29-4CC4-898B-6059B9758C2CQ24336045-7ED628C9-7FF6-4E56-8D61-684A30217B49Q24338421-13599EAE-65AB-490A-8ABC-7EBBC6E7DC81Q24603986-8754F418-6208-4200-B630-E318DB80DE00Q24613385-E51471B4-ECA5-4F3D-B163-258FBD2619CBQ24614424-EDF47ED7-95B5-44C6-8A50-54030999A3BAQ24623055-42624F63-5C52-4390-96C3-BD14A3BEE54BQ24627940-8855AA9B-4087-47D3-A0D3-E93B3BBA2D25Q24650089-A7610EC4-D15D-4DE1-903E-6FE6FB07AD98Q24657592-7A3844BC-8D72-435C-A047-9EDAADF12E32Q26738707-C3A2C382-227F-4976-A313-C67F0E33E97FQ26740308-3AF76A67-2B95-4528-9CD6-438A64AB1309Q26746889-1D163F70-69B4-4B5B-9711-B18AD0337A08Q26747621-1047F342-E6CD-4BBF-9C23-D4AB838BE13CQ26766578-A00EC19C-EEEF-43EA-A4A1-15A9F0E99129
P2860
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@ast
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@en
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@en-gb
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@nl
type
label
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@ast
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@en
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@en-gb
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@nl
prefLabel
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@ast
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@en
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@en-gb
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@nl
P2093
P2860
P3181
P356
P1433
P1476
Inactivation of YAP oncoprotei ...... tion and tissue growth control
@en
P2093
Arul Chinnaiyan
Georg Halder
Joungmok Kim
Keqiang Ye
Kun-Liang Guan
P2860
P304
P3181
P356
10.1101/GAD.1602907
P407
P577
2007-11-01T00:00:00Z